Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    IvyGPT: InteractiVe Chinese Pathway Language Model in Medical Domain

    General large language models (LLMs) such as ChatGPT have shown remarkable success. However, such LLMs have not been widely adopted for medical purposes, due to poor accuracy and inability to provide medical a...

    Rongsheng Wang, Yaofei Duan, ChanTong Lam, Jiexin Chen in Artificial Intelligence (2024)

  2. Article

    Open Access

    In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy

    Cancer immunotherapy that deploys the host’s immune system to recognize and attack tumors, is a promising strategy for cancer treatment. However, its efficacy is greatly restricted by the immunosuppressive (i....

    Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A. Kwizera in Nature Communications (2023)

  3. Article

    Open Access

    Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance

    The transmembrane P-glycoprotein (P-gp) pumps that efflux drugs are a major mechanism of cancer drug resistance. They are also important in protecting normal tissue cells from poisonous xenobiotics and endogen...

    Hai Wang, Yutong Liang, Yue Yin, Jie Zhang, Wen Su, Alisa M. White in Nature Communications (2021)

  4. Article

    Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Jiangsheng Xu, Yunhua Liu, Yu**g Li, Hai Wang, Samantha Stewart in Nature Nanotechnology (2020)

  5. Article

    Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

    The Supplementary Information originally published with this Article was an older version, in which ‘IFN-γ’ was misspelled ‘INF-γ’ in Supplementary Fig. 9 and the β-Actin blot in Supplementary Fig. 13 was the ...

    Jiangsheng Xu, Yunhua Liu, Yu**g Li, Hai Wang, Samantha Stewart in Nature Nanotechnology (2019)

  6. No Access

    Article

    Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

    TP53 is the most frequently mutated or deleted gene in triple negative breast cancer (TNBC). Both the loss of TP53 and the lack of targeted therapy are significantly correlated with poor clinical outcomes, making...

    Jiangsheng Xu, Yunhua Liu, Yu**g Li, Hai Wang, Samantha Stewart in Nature Nanotechnology (2019)

  7. Article

    Open Access

    Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

    Chromosome 17q23 amplification occurs in ~11% of human breast cancers. Enriched in HER2+ breast cancers, the 17q23 amplification is significantly correlated with poor clinical outcomes. In addition to the prev...

    Yunhua Liu, Jiangsheng Xu, Hyun Ho Choi, Cecil Han, Yuanzhang Fang in Nature Communications (2018)

  8. Article

    Open Access

    Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarction

    It is difficult to achieve minimally invasive injectable cell delivery while maintaining high cell retention and animal survival for in vivo stem cell therapy of myocardial infarction. Here we show that pluripote...

    Shuting Zhao, Zhaobin Xu, Hai Wang, Benjamin E. Reese in Nature Communications (2016)

  9. No Access

    Article

    Targeted anti-cancer prodrug based on carbon nanotube with photodynamic therapeutic effect and pH-triggered drug release

    Herein, we describe a multifunctional anti-cancer prodrug system based on water-dispersible carbon nanotube (CNT); this prodrug system features active targeting, pH-triggered drug release, and photodynamic the...

    Jianquan Fan, Fang Zeng, Jiangsheng Xu, Shuizhu Wu in Journal of Nanoparticle Research (2013)